The proinflammatory cytokines IL-1β and TNF-α, which are associated with inflammatory bowel diseases, disrupt epithelial cell-cell junctions by increasing the expression and activation levels of myosin light chain kinase (MLCK) (47–49). This evidence concerns the gene MYLK and inflammatory bowel disease.